Medical Breakthrough: Stryker’s Inari Medical Launches Artix Thrombectomy System

Before we delve into the Artix Thrombectomy System, let’s first get to know the "unsung heroes" behind its development. Inari Medical, now part of Stryker, has long been dedicated to medical solutions for venous thromboembolism and related conditions, offering a range of leading surgical products. As a global giant in medical technology, Stryker boasts a diverse product portfolio, including hospital beds, cleaning products, and various instruments used in orthopedic and neurosurgical procedures. The combination of these two powerhouses undoubtedly laid a solid foundation for the creation of the Artix Thrombectomy System.

With the acceleration of modern life pace and the intensification of population aging, the incidence of thrombosis-related diseases is on the rise. Thrombosis is like a "time bomb," which may pose a serious threat to patients' health at any time. As an important part of the human circulatory system, once thrombotic problems occur in the peripheral arterial system, it can lead to severe consequences such as limb ischemia, pain, ulcers, or even amputation. Existing treatment methods have many limitations; for example, ineffective clot repair may result in additional surgeries, such as open surgery or amputation. It may also cause adverse events like massive blood loss, arterial embolism, and vascular trauma, as well as a high rate of thrombolytic agent usage.

It is against this backdrop that the Artix Thrombectomy System was developed to meet the diverse needs of the peripheral arterial system. Its introduction marks Inari's first entry into the mainstream space and brings new hope for the treatment of peripheral arterial thrombosis.

The main unique features of the Artix system include:

• Dual Mechanical Thrombectomy and Aspiration ToolkitAiming to remove acute to chronic clots in a single treatment through a simplified procedure. It adopts a combined solution of aspiration and mechanical thrombectomy, equipping doctors with two "sharp tools" to handle thrombi with greater ease, significantly enhancing surgical control and versatility. The advantage of this combined solution lies in its ability to not only quickly and effectively remove thrombi but also reduce surgical risks and minimize the occurrence of complications, providing stronger assurance for patients' health.

• 8 Fr. Low-Profile, Trackable, Anti-Kink Sheaths in Lengths of 65 cm and 90 cmBy enabling more complex and distal interventions, it expands treatment options. Available in two lengths, doctors can flexibly adjust according to the patient's specific condition, broadening the range of treatment choices. It acts as a "customized pathway" tailored for each patient, ensuring the smooth progress of the procedure.

• Innovative OTW, designed to effectively collect acute to chronic thrombus.

• Funnel with Covered Nitinol MeshProvide temporary flow restriction during the procedure to minimize the risk of arterial clot migration.

Inari Medical Chief Medical Officer Dr. Tom Tu spoke highly of the Artix thrombectomy system, stating: "There is indeed a clinical need to address chronic thrombus and reduce the risk of clot migration. Artix will raise the standard for effective arterial thrombectomy. We are excited to bring Inari's core competence in thrombectomy to the arterial space with the goal of improving outcomes."

From a professional perspective, the emergence of the Artix thrombectomy system is undoubtedly a significant breakthrough in the field of peripheral arterial thrombosis treatment. It not only fills the gap in existing treatment methods but also brings new hope to patients. By improving the efficiency and safety of thrombectomy, Artix is expected to reduce the number of surgeries and the occurrence of complications, alleviate patient suffering and medical costs, enabling patients to recover more quickly and return to normal life.

The launch of the Artix Thrombectomy System is undoubtedly a significant transformation in the medical field, bringing new hope and possibilities for the treatment of peripheral arterial thrombosis. The emergence of this innovative technology not only reflects Inari Medical's profound technical accumulation and innovation capabilities in the medical field but also demonstrates Stryker's determination and strength in advancing medical technology.

With the continuous advancement of technology, the pace of innovation in the medical field is also constantly accelerating. We have reason to believe that the Artix thrombectomy system is just the beginning, and there will be more advanced medical technologies and devices like this in the future. They will continue to tackle medical challenges, improve the effectiveness of disease treatment, and bring more good news to patients.

This Issue's Planning: Shen Li

Editor-in-Chief: Chen Baolin

Author of this article: Yun Ye Xuan

Post-production: Zhang Lirong